Potassium Ion

Potassium Ion

SCHEMBL816755

CCCCC(CC)CC(CC(=O)[O-])(C(=O)[O-])S(=O)(=O)O.[K+].[K+]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CA2 P00918 5/20 0.46
RECQL P46063 1/20 0.37
ALDH1A1 P00352 4/20 0.35
CYP3A4 P08684 4/20 0.34
TSHR P16473 3/20 0.34
TDP1 Q9NUW8 2/20 0.34
ATM Q13315 1/20 0.34
MMP9 P14780 1/20 0.31
MMP8 P22894 1/20 0.31
MMP14 P50281 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6230350 0.97 CA2 (0.49) CA2RECQLALDH1A1CYP3A4TSHR
Silver SCHEMBL5574910 0.97 CA2 (0.46) CA2RECQLALDH1A1CYP3A4TSHR
SCHEMBL818559 0.97 CA2 (0.49) CA2RECQLALDH1A1CYP3A4TSHR
Lithium Ion SCHEMBL21747203 0.97 CA2 (0.46) CA2RECQLALDH1A1CYP3A4TSHR
SCHEMBL9326632 0.86 CA2 (0.46) CA2RECQLALDH1A1CYP3A4TSHR
SCHEMBL3816980 0.86 CA2 (0.49) CA2RECQLALDH1A1CYP3A4TSHR
Potassium Ion SCHEMBL11852844 0.85 RECQL (0.46) CA2RECQLALDH1A1CYP3A4TSHR
SCHEMBL10932205 0.83 CA2 (0.49) CA2RECQLALDH1A1CYP3A4TSHR
Silver SCHEMBL2027799 0.82 RECQL (0.46) CA2RECQLALDH1A1CYP3A4TSHR
SCHEMBL668755 0.82 RECQL (0.46) CA2RECQLALDH1A1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8440230-B2 Formulation based on micronized natural calcite mineral as a plant booster and mineral fertilizer MIKRO MINERAL USA, INC. (US) 2013-05-14 US claimed
US-20110269627-A1 FORMULATION BASED ON MICRONIZED NATURAL CALCITE MINERAL AS A PLANT BOOSTER AND MINERAL FERTILIZER MIKRO MINERAL USA, INC. 2011-11-03 US claimed
WO-2010097643-A1 FORMULATION BASED ON MICRONIZED ZEOLITE, GREEN TEA EXTRACT, AND GENISTEIN AS A THERAPEUTIC AGENT FOR REDUCTION OF BODY WEIGHT AND CELLULITE NOVATECH ISTRAZIVANJE D.O.O. (HR) 2010-09-02 WO claimed
US-7758684-B2 Ink additive and ink using same NISSIN CHEMICAL INDUSTRY CO., LTD. (JP) 2010-07-20 US claimed
WO-2010018418-A1 FORMULATION BASED ON MICRONIZED CLINOPTILOLITE AS THERAPEUTIC AGENT PROVIDING HIGHLY BIOAVAILABLE SILICON NOVATECH D.O.O. (HR) 2010-02-18 WO claimed
WO-2009087426-A1 FORMULATION BASED ON MICRONI ZED NATURAL CALCITE MINERAL AS A PLANT BOOSTER AND MINERAL FERTILIZER NOVATECH D.O.O. (HR) 2009-07-16 WO claimed
US-20070283845-A1 Ink additive and ink using same NISSIN CHEMICAL INDUSTRY CO., LTD. (JP) 2007-12-13 US claimed
US-20200165439-A1 THERMOPLASTIC RESIN COMPOSITION LG CHEM, LTD. (KR) 2020-05-28 US disclosed
EP-3613807-A1 THERMOPLASTIC RESIN COMPOSITION LG Chem, Ltd. (KR) 2020-02-26 EP disclosed
US-8440230-B2 Formulation based on micronized natural calcite mineral as a plant booster and mineral fertilizer MIKRO MINERAL USA, INC. (US) 2013-05-14 US disclosed
US-20110269627-A1 FORMULATION BASED ON MICRONIZED NATURAL CALCITE MINERAL AS A PLANT BOOSTER AND MINERAL FERTILIZER MIKRO MINERAL USA, INC. 2011-11-03 US disclosed
US-20110224080-A1 FORMULATION BASED ON MICRONIZED NATURAL CALCITE MINERAL AND MICRONIZED ZEOLITE AS AN ENHANCED PLANT BOOSTER AND MINERAL FERTILIZER MIKRO MINERAL USA, INC. 2011-09-15 US disclosed
WO-2010097643-A1 FORMULATION BASED ON MICRONIZED ZEOLITE, GREEN TEA EXTRACT, AND GENISTEIN AS A THERAPEUTIC AGENT FOR REDUCTION OF BODY WEIGHT AND CELLULITE NOVATECH ISTRAZIVANJE D.O.O. (HR) 2010-09-02 WO disclosed
US-7758684-B2 Ink additive and ink using same NISSIN CHEMICAL INDUSTRY CO., LTD. (JP) 2010-07-20 US disclosed
WO-2010018418-A1 FORMULATION BASED ON MICRONIZED CLINOPTILOLITE AS THERAPEUTIC AGENT PROVIDING HIGHLY BIOAVAILABLE SILICON NOVATECH D.O.O. (HR) 2010-02-18 WO disclosed
WO-2009087426-A1 FORMULATION BASED ON MICRONI ZED NATURAL CALCITE MINERAL AS A PLANT BOOSTER AND MINERAL FERTILIZER NOVATECH D.O.O. (HR) 2009-07-16 WO disclosed
US-20070283845-A1 Ink additive and ink using same NISSIN CHEMICAL INDUSTRY CO., LTD. (JP) 2007-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224080-A1 FORMULATION BASED ON MICRONIZED NATURAL CALCITE MINERAL AND MICRONIZED ZEOLITE AS AN ENHANCED PLANT BOOSTER AND MINERAL FERTILIZER MAX, CAMK2G, SLC39A3 CA2 20/4885RECQL 1670/4885ALDH1A1 4885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.